Target intelligence / Profile preview

Local vaginal microenvironment (VME)

Target
VME
Molecular classification
Other
01

Overview

The local vaginal microenvironment is a dynamic and complex ecosystem consisting of the vaginal microbiota, host mucosal epithelium, and various biochemical constituents such as lactic acid, hydrogen peroxide, and antimicrobial peptides (Ravel et al., 2011). Its primary biological function is to maintain a protective barrier against urogenital pathogens, largely through the dominance of Lactobacillus species that produce lactic acid to maintain an acidic pH, typically between 3.5 and 4.5 (Miller et al., 2016). Dysregulation of this environment, often termed dysbiosis, is a hallmark of conditions such as bacterial vaginosis (BV) and vulvovaginal candidiasis, and it significantly increases the risk of acquiring sexually transmitted infections (STIs) and experiencing adverse pregnancy outcomes like preterm birth (Borges et al., 2014). While the microenvironment itself is not a single molecular target, it is a therapeutic focus for interventions aimed at restoring homeostasis, including the use of probiotics, pH-restoring gels, and localized anti-infectives (Mendling et al., 2019). Drugs like metronidazole and clindamycin are used to eliminate overgrowth of anaerobic bacteria, while emerging live biotherapeutic products (LBPs) seek to re-establish a Lactobacillus-dominant state (Cohen et al., 2020). Monitoring the health of this microenvironment involves assessing biomarkers such as vaginal pH, the Nugent score, and specific cytokine profiles to evaluate the efficacy of treatments and the risk of disease progression (Amabebe & Anumba, 2018).

Other names
Vaginal ecosystemVaginal nicheVaginal microbiota-host interfaceVaginal environment
02

Mechanism of action

Modulation of microbial composition, restoration of acidic pH, and enhancement of mucosal barrier integrity.

03

Biological functions

Immune responseBarrier functionMicrobial homeostasisMetabolism
04

Disease associations

InfectionInflammationBacterial vaginosisPreterm birthSexually transmitted infections
05

Safety considerations

Risk of secondary infections (e.g., yeast overgrowth)Local irritationDisruption of commensal floraSystemic absorption of localized treatments
06

Interacting drugs

Metronidazole

5 more in the full profile.

07

Biomarkers

Vaginal pHNugent scoreLactic acid concentrationLactobacillus abundancePro-inflammatory cytokines (e.g., IL-1beta)

Beyond the preview

Go deeper on Local vaginal microenvironment (VME).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Local vaginal microenvironment (VME).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call